To identify pan-cancer molecular drivers in patients exhibiting RBness in the absence of known RB1 defects, we interrogated TCGA molecular datasets to test for enrichment of somatic mutations, amplifications, and deletions using high-confidence cancer driver genes (table S12; Materials and Methods: Association with candidate driver alterations) (58). This evidence concerns the gene RB1 and cancer.